Home › Drug developer Virobay lines up $50M IPO
 

Keywords :   


Drug developer Virobay lines up $50M IPO

2014-09-11 08:15:58| Biotech - Topix.net

Drug developer Virobay Inc. hopes to raise $50 million in an initial public offering for a critical year of clinical trials, according to the Menlo Park company's U.S. Securities and Exchange Commission filing Wednesday. The offering is the latest in a line of Bay Area biotech IPOs, including ones that could hit the market yet this month.

Tags: lines drug developer ipo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »